Latest Breaking News On - Pacificr trial - Page 1 : comparemela.com

Treatment with durvalumab was associated with lower real-world progression-free survival in patients with unresectable, stage III EGFR-mutated non–small cell lung cancer vs patients with EGFR wild-type disease.

Solange petersOsimertinib tagrissoInternational associationDepartment of oncologyUniversity hospital of lausanneLung cancerUniversity hospitalClin lungIaslc world conference on lung cancerPacificr trialInternational association for the study of lung cancer 2023 world conference on